The rare blood groups: A public health challenge;Les phénotypes érythrocytaires rares : un enjeu de santé publique

Transfusion Clinique et Biologique

Volumn 15, Issue 3, 2008, Pages 109-119

  Peyrard, T ^a   Pham, B N ^a   Le Pennec, P Y ^a   Rouger, P ^a  

^a INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

Author keywords

Alloimmunization; Blood group; High prevalence antigen; Rare blood; Rare blood group; Sickle cell disease; Transfusion safety

Indexed keywords

ANTIBODY; ANTIGEN;

ANTIBODY SPECIFICITY; BLOOD BANK; BLOOD COMPATIBILITY; BLOOD DONOR; BLOOD GROUP; BLOOD TRANSFUSION; CELL TYPE; FOLLOW UP; GENOTYPE; PHENOTYPE; POPULATION; PREGNANCY; PREVALENCE; PUBLIC HEALTH; SHORT SURVEY; SOCIOECONOMICS; SOCIOLOGY;

BLOOD BANKS; BLOOD DONORS; BLOOD GROUP ANTIGENS; BLOOD GROUPING AND CROSSMATCHING; BLOOD PRESERVATION; BLOOD TRANSFUSION; COST-BENEFIT ANALYSIS; CRYOPRESERVATION; FEMALE; FRANCE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; PREGNANCY; PUBLIC HEALTH; REGISTRIES; SOCIOECONOMIC FACTORS;

EID: 47949084989     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tracli.2008.02.001     Document Type: Short Survey

References (22)

1. Daniels G.L., Fletcher A., Garratty G., Henry S., Jorgensen J., Judd W.J., et al. Blood group terminology 2004: from the International Society of Blood Transfusion committee on terminology for red cell surface antigens. Vox Sang (2004) 304-315
2. Arrêté du 28 décembre 1995 relatif aux conditions d'utilisation de prélèvements de sang ou de composants du sang correspondant à des groupes sanguins érythrocytaires rares, pris pour l'application de l'article D.666-4-2 du Code de la santé publique. Publié au Journal Officiel de la République française le 13 janvier 1996.
3. Daniels G. Human Blood Groups. 2nd ed. (2002), Blackwell Science, Oxford
4. Reid M., and Lomas-Francis C. The blood group antigen FactsBook. 2nd ed. (2004), Elsevier Academic Press, London
5. Reid M., and Lomas-Francis C. Blood group antigens & antibodies (2007), SBB Books, New York
6. o 97/57 du 31 janvier 1997 relative à la transfusion autologue en chirurgie. Parue au Bulletin Officiel Santé du 23 mars 1997.
7. Noizat-Pirenne F., Lee K., Le Pennec P.Y., Simon P., Kazup P., Bachir D., et al. Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety. Blood (2002) 4223-4231
8. Les immigrés en France - Insee Collection Références Édition 2005.
9. Peyrard T., Fialaire-Legendre A., Noizat-Pirenne F., Bierling P., Rouger P., and Le Pennec P.Y. Exceptional phenotypes in a national file of individuals presenting a rare blood group. Transfusion 46 Suppl. 133A (2006)
10. Peyrard T., Fialaire-Legendre A., Noizat-Pirenne F., Bierling P., Rouger P., and Le Pennec P.Y. A national file of individuals presenting a rare blood phenotype and a national blood bank for rare blood units: a five-year experience. Transfusion 46 Suppl. 132A (2006)
11. Price C.L., Boyd J.H., Watkins A.R., Fleming F., and DeBaun M.R. Mailing of a sickle cell disease educational packet increases blood donors within an African American community. Transfusion 46 (2006) 1388-1393
12. Boulware L.E., Ratner L.E., Ness P.M., Cooper L.A., Campbell-Lee S., LaVeist T.A., et al. The contribution of sociodemographic, medical, and attitudinal factors to blood donation among the general public. Transfusion 42 (2002) 669-678
13. Ferguson E., France C.R., Abraham C., Ditto B., and Sheeran P. Improving blood donor recruitment and retention: integrating theoretical advances from social and behavioral science research agendas. Transfusion 47 (2007) 1999-2010
14. Le Pennec P.Y., Noizat-Pirenne F., Ansart-Pirenne H., and Rouger P. A national file for individuals (patients and donors) presenting a rare blood group. Vox Sang 83 Suppl. 2 (2002) 10-11
15. Woodfield G., and Novaretti M. Rare blood, an international survey. Transfus Today 48 (2001) 6-7
16. Anstee D., Levene C., Mallory D., Overbeeke M., Poole J., Reid M., et al. Rare blood. Vox Sang 77 (1999) 58-62
17. Woodfield G. Rare blood donors: the past and the future. Vox Sang 83 Suppl. 1 (2002) 93-97
18. Woodfield G. A review of the ISBT rare blood donor program. Immunohematology 20 (2004) 244-248
19. Poole J. The screening, identification and use of rare blood. Vox Sang 83 Suppl. 1 (2002) 99-100
20. Seltsam A., Wagner F.F., Salama A., and Flegel W. Antibodies to high-frequency antigens may decrease the quality of transfusion support: an observational study. Transfusion 43 (2003) 1563-1566
21. ISBT working party on rare donors. Transfus Today 2007;71:15.
22. Rouger P & the EuroNet-TMS. Blood transfusion in Europe: The White Book 2005. Paris: Elsevier SAS;2005.